Long Term Follow Up Study of the St. Jude Medical Trifecta Valve

This study is enrolling participants by invitation only.
Information provided by (Responsible Party):
St. Jude Medical
ClinicalTrials.gov Identifier:
First received: May 4, 2012
Last updated: September 9, 2015
Last verified: September 2015
To collect long term follow up study data of the Trifecta valve in subjects who had the Trifecta valve implanted during the IDE study.

Aortic Valve Insufficiency
Aortic Valve Regurgitation
Aortic Valve Stenosis
Aortic Valve Incompetence

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Long Term Follow Up Study of the St. Jude Medical Trifecta™ Valve

Resource links provided by NLM:

Further study details as provided by St. Jude Medical:

Primary Outcome Measures:
  • Collecting long term valve related events [ Time Frame: 10 years ] [ Designated as safety issue: No ]
    The primary objective is to collect long-term study data including long term valve-related events of the Trifecta valve

Estimated Enrollment: 650
Study Start Date: June 2012
Estimated Study Completion Date: April 2020
Estimated Primary Completion Date: April 2020 (Final data collection date for primary outcome measure)
Subjects previously implanted with a Trifecta valve
Subjects enrolled in this clinical study received the Trifecta valve during the investigational study that was conducted to obtain FDA approval


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects previously implanted with a Trifecta prosthetic valve

Inclusion Criteria:

  • Patient currently has a Trifecta valve that was implanted
  • Patient met eligibility criteria prior to enrollment in the Trifecta IDE study
  • Patient agrees to complete all required follow-up visits
  • Patient provided written informed consent prior to any study related procedure as approved by the governing Institutional Review Board or the Ethics Committee of the investigational site

Exclusion Criteria:

  • Patient is currently participating or planning to participate in any other study unless approved by SJM
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01593917

United States, California
Keck School of Medicine of University of Southern California
Los Angeles, California, United States, 90033
United States, Ohio
Cleveland Clinic
Cleveland, Ohio, United States, 44195
United States, Pennsylvania
Lankenau Medical Center
Wynnewood, Pennsylvania, United States, 19096
Canada, British Columbia
University of British Columbia Department of Surgery, Division of Cardiovascular Surgery; St. Paul's Hospital
Vancouver, British Columbia, Canada, V6J 2G7
Institut Universitaire de Cardiologie et Pneumologie de Quebec
Quebec, Canada, G1V 4G5
Sponsors and Collaborators
St. Jude Medical
Study Director: Urban Lonn, MD St. Jude Medical
  More Information

Responsible Party: St. Jude Medical
ClinicalTrials.gov Identifier: NCT01593917     History of Changes
Other Study ID Numbers: 1104 
Study First Received: May 4, 2012
Last Updated: September 9, 2015
Health Authority: United States: Institutional Review Board

Keywords provided by St. Jude Medical:
Aortic valve
Heart valve
Tissue valve

Additional relevant MeSH terms:
Aortic Valve Insufficiency
Aortic Valve Stenosis
Cardiovascular Diseases
Heart Diseases
Heart Valve Diseases
Ventricular Outflow Obstruction

ClinicalTrials.gov processed this record on May 22, 2016